Home NDC 49781-089 leader loperamide
Product NDC 49781-089
11-digit product format 497810089
Labeler code 49781
Product ID 49781-089_0beba1ac-7c94-4e36-ad14-08a5933a6f2c
Type HUMAN OTC DRUG
Nonproprietary name Loperamide Hydrochloride
Dosage form SUSPENSION
Route ORAL
Labeler Cardinal Health
Application ANDA091292
Marketing category ANDA
Marketing start 2014-05-30
Marketing end 2020-03-01
Substance LOPERAMIDE HYDROCHLORIDE
Active strength 1 mg/7.5mL
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 49781-089-04 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 49781-089-04 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 49781-089-04 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 49781-089-04 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 49781-089-04 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 49781-089-04 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 49781-089-04 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 49781-089-04 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 49781-089-04 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 49781-089-04 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 49781-089-04 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 49781-089-04 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A091292-001 LOPERAMIDE HYDROCHLORIDE LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SOLUTION / ORAL 2011-05-20
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SOLUTION / ORAL 2011-05-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SOLUTION / ORAL 2011-05-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A091292-001 LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML SUSPENSION / ORAL 2011-05-20 cb3db0bc1861…
DailyMed Socrata Ingredients# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 2 · 26 matching rows.